Argyle Capital Partners’s Alerian MLP Index ETNs due January 28 2044 AMJB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.55M Sell
73,946
-756
-1% -$27.7K 1.58% 11
2026
Q2
$2.58M Buy
74,702
+4,098
+6% +$143K 1.62% 11
2026
Q1
$2.44M Sell
70,604
-3,251
-4% -$108K 1.76% 10
2025
Q4
$2.21M Buy
73,855
+3,038
+4% +$90.3K 1.61% 13
2025
Q3
$2.09M Buy
+70,817
New +$2.15M 1.5% 14

Other funds holding AMJB

Argyle Capital Partners's AMJB Position: Q3 2026 in Review

Argyle Capital Partners reduced its Alerian MLP Index ETNs due January 28 2044 (AMJB) stake by 1% in Q3 2026, selling an estimated $27.7K and leaving 73,946 shares worth $2.55M. The position accounts for 1.58% of the portfolio, ranked #11.

Argyle Capital Partners first reported a position in AMJB in Q3 2025 and has held it in 5 quarters since. The position peaked at $2.58M in Q2 2026. 19 funds tracked by Wall St. Rank hold AMJB as of Q3 2026.

  • Argyle Capital Partners held 73,946 shares of Alerian MLP Index ETNs due January 28 2044 worth $2.55M as of Q3 2026.
  • Argyle Capital Partners sold 756 Alerian MLP Index ETNs due January 28 2044 shares in Q3 2026, an estimated $27.7K.
  • Alerian MLP Index ETNs due January 28 2044 made up 1.58% of Argyle Capital Partners's portfolio in Q3 2026, its #11 holding.
  • Argyle Capital Partners first reported a position in Alerian MLP Index ETNs due January 28 2044 in Q3 2025 and has held it in 5 quarters since.
  • Argyle Capital Partners's Alerian MLP Index ETNs due January 28 2044 position peaked at $2.58M in Q2 2026.
  • 19 funds tracked by Wall St. Rank held Alerian MLP Index ETNs due January 28 2044 as of Q3 2026.

Based on Argyle Capital Partners's 13F filing for Q3 2026, filed 23 Oct 2026.